Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00196_DB08895_nanopub.RAVVjAOg20XdvFiJYPVjro6K60yeFaBteTQKesWmDumgQ#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00196_DB08895 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00196_DB08895 label "DDI between Fluconazole and Tofacitinib - Fluconazole (and other strong CYP2C19 inhibitors and moderate CYP3A4 inhibitors), when used in combination with tofacitinib, may increase tofacitinib concentration. It is recommended to modify therapy by reducing the adult dose of tofacitinib from 5mg twice a day to 5mg daily. [drugbank_resource:DB00196_DB08895]" assertion.
- drugbank_resource:DB00196_DB08895 identifier "drugbank_resource:DB00196_DB08895" assertion.
- drugbank_resource:DB00196_DB08895 title "DDI between Fluconazole and Tofacitinib - Fluconazole (and other strong CYP2C19 inhibitors and moderate CYP3A4 inhibitors), when used in combination with tofacitinib, may increase tofacitinib concentration. It is recommended to modify therapy by reducing the adult dose of tofacitinib from 5mg twice a day to 5mg daily." assertion.
- drugbank:DB00196 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00196_DB08895 assertion.
- drugbank:DB08895 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00196_DB08895 assertion.